参考文献/References:
[1] Nishiyama Y,Ueda M.Katsura KI er al.ALsymmetric dimethylarginine(ADMA)as a possible risk marker for ischemic stroke[J].Neuro Sci,2010,290(1/2):12-15.
[2] Andreozzi F,Presta I,Mannino GC,et al.A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is asslciated with insuLin sensitivity[J].PLoS One,2012,7(4):e36224.
[3] Luenebur N,Maas R,Lieb W,et al.Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension[J].Nitric Oxide-Biology and Chemistry,2008,19(S):S40.
[4] 李粲,韩莉娜,霍富元,等.2012年广州市海珠区居民脑卒中患病率及相关危险因素调查分析[J].热带医学杂志,2013,13(6):712-715.
[5] Yoo JH,Lee SC.Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke[J].Atherosclerosis,2001,158(2):425-430.
[6] Wilson AM,Shin DS,Weatherby C,et al.Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease[J].Vascular Medicine,2010,15(4):267-274.
[7] Tran CT,Fox MF,Vallance P,et al.Chromosomal localizarion,gene structure,and expression pattern of DDAH:comparison with DDAH2 and implications for evolutionary origins[J].Genomics,2000,68(1):101-105.